134 related articles for article (PubMed ID: 11943142)
21. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
22. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1.
Marinari B; Costanzo A; Viola A; Michel F; Mangino G; Acuto O; Levrero M; Piccolella E; Tuosto L
Eur J Immunol; 2002 Feb; 32(2):447-56. PubMed ID: 11813163
[TBL] [Abstract][Full Text] [Related]
23. Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.
Doody GM; Billadeau DD; Clayton E; Hutchings A; Berland R; McAdam S; Leibson PJ; Turner M
EMBO J; 2000 Nov; 19(22):6173-84. PubMed ID: 11080163
[TBL] [Abstract][Full Text] [Related]
24. A functional T-cell receptor signaling pathway is required for p95vav activity.
Wu J; Katzav S; Weiss A
Mol Cell Biol; 1995 Aug; 15(8):4337-46. PubMed ID: 7623828
[TBL] [Abstract][Full Text] [Related]
25. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-gamma promoter that is a potential NFAT binding site.
Campbell PM; Pimm J; Ramassar V; Halloran PF
Transplantation; 1996 Mar; 61(6):933-9. PubMed ID: 8623163
[TBL] [Abstract][Full Text] [Related]
26. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element.
Ye J; Cippitelli M; Dorman L; Ortaldo JR; Young HA
Mol Cell Biol; 1996 Sep; 16(9):4744-53. PubMed ID: 8756632
[TBL] [Abstract][Full Text] [Related]
27. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter.
Sica A; Dorman L; Viggiano V; Cippitelli M; Ghosh P; Rice N; Young HA
J Biol Chem; 1997 Nov; 272(48):30412-20. PubMed ID: 9374532
[TBL] [Abstract][Full Text] [Related]
28. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
29. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
30. Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells.
Lindholm CK; Henriksson ML; Hallberg B; Welsh M
Eur J Biochem; 2002 Jul; 269(13):3279-88. PubMed ID: 12084069
[TBL] [Abstract][Full Text] [Related]
31. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
32. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways.
Mengshol JA; Vincenti MP; Brinckerhoff CE
Nucleic Acids Res; 2001 Nov; 29(21):4361-72. PubMed ID: 11691923
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.
Ma W; Gee K; Lim W; Chambers K; Angel JB; Kozlowski M; Kumar A
J Immunol; 2004 Jan; 172(1):318-30. PubMed ID: 14688340
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
35. Mucosa-specific targets for regulation of IFN-gamma expression: lamina propria T cells use different cis-elements than peripheral blood T cells to regulate transactivation of IFN-gamma expression.
Gonsky R; Deem RL; Bream JH; Lee DH; Young HA; Targan SR
J Immunol; 2000 Feb; 164(3):1399-407. PubMed ID: 10640755
[TBL] [Abstract][Full Text] [Related]
36. c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1.
Shapiro VS; Mollenauer MN; Greene WC; Weiss A
J Exp Med; 1996 Nov; 184(5):1663-9. PubMed ID: 8920856
[TBL] [Abstract][Full Text] [Related]
37. SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity.
Fang N; Koretzky GA
J Biol Chem; 1999 Jun; 274(23):16206-12. PubMed ID: 10347175
[TBL] [Abstract][Full Text] [Related]
38. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
39. RhoG regulates gene expression and the actin cytoskeleton in lymphocytes.
Vigorito E; Billadeu DD; Savoy D; McAdam S; Doody G; Fort P; Turner M
Oncogene; 2003 Jan; 22(3):330-42. PubMed ID: 12545154
[TBL] [Abstract][Full Text] [Related]
40. Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun.
Cippitelli M; Sica A; Viggiano V; Ye J; Ghosh P; Birrer MJ; Young HA
J Biol Chem; 1995 May; 270(21):12548-56. PubMed ID: 7759501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]